European Neuropsychopharmacology
- A European perspective on tardive dyskinesia8 hours ago
- Efficacy of xanomeline and xanomeline trospium in the treatment of cognitive impairment: A systematic review of preclinical and clinical trials1 day ago
- All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kong1 day ago
- Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study2 days ago
- Ayahuasca modulation of traumatic-like fear memories requires infralimbic cortex BDNF-dependent mechanisms in rats2 days ago
- Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial5 days ago
- Are cell type-specific methylation profiles the missing link in ADHD epigenetics?6 days ago
- Dynamic functional network connectivity impairment in bipolar disorder and its relationship with global functioning1 week ago
- Different effect of adverse childhood experiences on white matter microstructure in major depression and bipolar disorder: moderating role of genetic liability1 week ago
- Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients1 week ago
- Editorial Board1 week ago
- The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)2 weeks ago
- Psychedelics: The pathway to implementation in the European healthcare systems2 weeks ago
- Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and Kpuu3 weeks ago
- Corrigendum to “Does bipolar disorder accelerate cellular aging? A systematic review and meta-analysis of telomere length” [European Neuropsychopharmacology; 2025;99:21-30]3 weeks ago
- Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach3 weeks ago
- Editorial Board4 weeks ago
- Three shades of gloom: investigating the genetic background of current depressive symptoms associated with different severity of current stress exposure in a general population4 weeks ago
- Reply to the commentary on “Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”4 weeks ago
- Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer’s disease, obesity and type 2 diabetes4 weeks ago
- Patterns, predictors and outcomes of trajectories for subjective quality of life in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention4 weeks ago
- Persistent mortality gap in schizophrenia: current challenges and future directions4 weeks ago
- Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis1 month ago
- Chronic stress and brain kynurenine pathway: addressing unresolved issues with a meta-analytic approach of preclinical studies, translational implication for psychiatric disorders1 month ago
- Commentary on the article “Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”2 months ago
- A call for more robust and interpretable models in predicting treatment-resistant depression2 months ago
- Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort2 months ago
- Response to the letter regarding “Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine”2 months ago
- Cell type-specific methylome-wide association studies of childhood ADHD symptoms2 months ago
- Is psychosis an obstetric condition? Revisiting the role of early-life environmentally stressful events2 months ago
- Toward rigorous control conditions in trials of digital therapeutics2 months ago
- Editorial Board2 months ago
- Structural connectomic signatures of childhood maltreatment across affective and psychotic disorders2 months ago
- Single-cell atlas of schizophrenia peripheral immunity implicates neutrophil-driven inflammation and adaptive immune suppression3 months ago
- Response to Commentaries on Article: “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”3 months ago
- Machine learning and neuroimaging in mood disorders: A promising path forward3 months ago
- Comment on “Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction”3 months ago
- Response to the letter to the editor: “Compressed design, inflated conclusions? A cautionary note on vaporized DMT trials”3 months ago
- Reply from the Authors3 months ago
- Esketamine in bipolar depression: Are we overlooking critical subgroups and dosing details?3 months ago
- Reply to Jianjie Ju and Hui Chen3 months ago
- The potential of applying large-scale multi-omics data to unsupervised learning-based transdiagnostic clusters of individuals with severe mental disorders to identify pharmacodynamic targets3 months ago
- Editorial Board3 months ago
- Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations3 months ago
- Methodological gaps in treatment-resistant depression prediction4 months ago
- Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis4 months ago
- Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations4 months ago
- Letter to “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”4 months ago
- Letter to the editor: Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: Findings from the OPTiMiSE trial4 months ago
- Intraparietal sulcus depth is associated with negative symptomatology in patients with first-episode psychosis4 months ago
- Letter to the Editor: On clinical predictors of treatment-resistant depression: Comments on validation strategy, predictor independence, and clinical implementation4 months ago
- Strategies for improving research on semaglutide in cocaine use disorder4 months ago
- Do patients benefit from collaborations between industry and academia in psychopharmacological research?4 months ago
- Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction4 months ago
- Editorial Board4 months ago
- ’’Does bipolar disorder accelerate cellular aging? A systematic review and meta-analysis of telomere length”4 months ago
- Clozapine in treatment-resistant early-onset schizophrenia: A two-year follow-up retrospective observational study4 months ago
- Blood-based biomarkers of neuroaxonal and astroglial injury identify ultra-treatment-resistant schizophrenia5 months ago
- Commentary on the Article “Differences in resting-state functional connectivity between depressedbipolar and major depressive disorder patients: A machine learning study”5 months ago
- “Compressed design, inflated conclusions?” A cautionary note on vaporized DMT trials5 months ago
- Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine: A one-year retrospective cohort study of 2126 patients5 months ago
- The genetics of treatment-resistant depression: controversies and perspectives5 months ago
- Fifty years of pharmacotherapy for obsessive-compulsive disorder – A short reflection5 months ago
- Editorial Board5 months ago
- Therapygenetics: Serotonin transporter gene polymorphism (5-HTTLPR) is associated with behavioral treatment response to virtual exposure therapy in patients with spider phobia5 months ago
- Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial5 months ago
- Inflammation–neurotrophin interplay and depression outcomes: authors’ reply5 months ago
- Clinical predictors of treatment resistant depression5 months ago
- Genetic variants of uncertain significance in psychiatry and the potential for confusion among patients and clinicians alike5 months ago
- Emotional cognition in patients with borderline personality disorder and patients with bipolar disorder type II: Evidence for transdiagnostic and differential diagnostic differences?5 months ago
- Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens5 months ago
- Orexin receptor antagonists: Potential as novel antidepressants and anxiolytics5 months ago
- The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial6 months ago
- Transcriptome meta-analysis of valproic acid exposure: A new approach in human brain organoids6 months ago
- Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment6 months ago
- Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study6 months ago
- Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial6 months ago
- Strategies for optimizing brain-predicted age difference (Brain-PAD) Models6 months ago
- Psychotropic drug-dependent modulation of excitatory-inhibitory balance in the prefrontal cortex of rats exposed to acute footshock stress6 months ago
- Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”6 months ago
- Interplay of serum IL-1β and BDNF in antidepressant response: Promise and challenges for clinical translation6 months ago
- Social belief updating in bipolar disorder and childhood maltreatment: A novel direction for research and clinical practice6 months ago
- Editorial Board6 months ago
- Pharmacological profiling of major depressive disorder-related multimorbidity clusters7 months ago
- Age at onset and trajectory to mania7 months ago
- Thinner and wiser? Prospects of GLP-1 agonists in psychiatry7 months ago
- Targeting hallucinations in schizophrenia: Improving research translation into clinical practice7 months ago
- Making symptom measurement feasible: The clinical case for PANSS-67 months ago
- Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong7 months ago
- Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials7 months ago
- Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003–20187 months ago
- Functioning Assessment Short Test (FAST): validity and reliability in adolescent and young adults with Borderline Personality Disorder (BPD)7 months ago
- Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis7 months ago
- Attention to the quality of methods is critical for valuable research: some examples relevant for animal models of psychiatric disorders7 months ago
- Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database8 months ago
- Exploring the prospective association of serum interleukin-1β and brain-derived neurotrophic factor with antidepressant treatment response8 months ago
- Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study8 months ago
- Longitudinal brain age in first-episode mania youth treated with lithium or quetiapine8 months ago
- Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”8 months ago
- Egr2 Modulation in the Medial Prefrontal Cortex Regulates Resistance to Stress-Induced Memory Impairments8 months ago